Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 26, 2014	Mar. 27, 2013
Cash flows from operating activities:
Net income	$ 6,431	$ 7,081
Adjustments to reconcile net income to cash flows provided by operating activities:
Depreciation and amortization	5,238	5,224
Operating (gains), losses and other charges, net	422	134
Amortization of deferred financing costs	121	133
(Gain) loss on early extinguishment of debt	(1)	349
Loss on change in the fair value of interest rate caps	10	2
Deferred income tax expense	2,159	2,875
Share-based compensation	1,164	1,175
Decrease (increase) in assets:
Receivables	2,836	2,398
Inventories	(36)	(35)
Other current assets	1,478	2,218
Other assets	(586)	(1,036)
Increase (decrease) in liabilities:
Accounts payable	3,306	(2,658)
Accrued salaries and vacations	(3,967)	(5,574)
Accrued taxes	(320)	(117)
Other accrued liabilities	(3,961)	(2,679)
Other noncurrent liabilities and deferred credits	(963)	(2,135)
Net cash flows provided by operating activities	13,331	7,355
Cash flows from investing activities:
Capital expenditures	(6,857)	(3,006)
Proceeds from disposition of property	4	22
Collections on notes receivable	727	1,234
Issuance of notes receivable	(305)	(404)
Net cash flows used in investing activities	(6,431)	(2,154)
Cash flows from financing activities:
Net revolver borrowings under new credit agreement	3,000	0
Long-term debt payments	(1,746)	(5,072)
Proceeds from exercise of stock options	44	688
Tax withholding on share-based payments	(419)	(464)
Tax expense for share-based compensation	(275)	(97)
Purchase of treasury stock	(8,596)	(2,272)
Net bank overdrafts	(437)	(1,286)
Net cash flows used in financing activities	(8,429)	(8,503)
Decrease in cash and cash equivalents	(1,529)	(3,302)
Cash and cash equivalents at beginning of period	2,943	13,565
Cash and cash equivalents at end of period	$ 1,414	$ 10,263